Omeros | OMER - Market Capitalization


Omeros reported $1.2B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Pacira USD 998M 83M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026